CNR1 and triple-negative breast carcinoma: CB1 and CB2 receptors are located in cancer cells of triple-negative breast cancer and high-grade glioma, but also in pancreatic duct epithelial carcinoma cells and colon cancer cells, including those of the SW-620 cell line [23,24,25].